|Articles|April 25, 2017
Schulman IRBs IBC Service to Launch in May
Schulman IRB announced its commercial institutional biosafety committee (IBC) service will launch in May 2017.
Advertisement
Schulman IRB announced its commercial institutional biosafety committee (IBC) service will launch in May 2017. The IBC service represents Schulman’s response to requests from research sponsors, CROs and institutions seeking an independent option for establishing IBCs when required by federal guidelines.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Gilead’s ARTISTRY-2 Trial Shows Bictegravir Lenacapavir Combo Matches Biktarvy in Virologically Suppressed Adults With HIV
2
When AI Learns to Speak Every Language: An eCOA Migration Study
3
Using Digital Tools to Enhance Patient-Centric Trials
4
Preparing for End-to-End AI-Enabled Clinical Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
